Search research articles
Contact Us
Filters
Showing results (591-600 of 611) with videos related to
Page
of 62
Sort By:
Physical Review Letters
|
March 24, 2005
Measurement of the transverse beam spin asymmetry in elastic electron-proton scattering and the inelastic contribution to the imaginary part of the two-photon exchange amplitude
F E Maas, K Aulenbacher, S Baunack, et al.
Journal of Crohn'S & Colitis
|
January 5, 2025
A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn's perianal fistulas
Michael De Gregorio, Leon S Winata, Imogen Hartley, et al.
Physical Review Letters
|
July 22, 2017
New Measurements of the Beam Normal Spin Asymmetries at Large Backward Angles with Hydrogen and Deuterium Targets
D Balaguer Ríos, K Aulenbacher, S Baunack, et al.
Physical Review Letters
|
June 13, 2009
Measurement of strange quark contributions to the vector form factors of the proton at Q2 = 0.22 (GeV / c)2
S Baunack, K Aulenbacher, D Balaguer Ríos, et al.
Physical Review Letters
|
April 14, 2020
Study of Two-Photon Exchange via the Beam Transverse Single Spin Asymmetry in Electron-Proton Elastic Scattering at Forward Angles over a Wide Energy Range
B Gou, J Arvieux, K Aulenbacher, et al.
Physical Review Letters
|
May 21, 2005
Evidence for strange-quark contributions to the nucleon's form factors at Q2=0.108 (GeV/c)2
F E Maas, K Aulenbacher, S Baunack, et al.
Plos One
|
January 4, 2014
Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents
Leslie W Tari, Xiaoming Li, Michael Trzoss, et al.
Physical Review Letters
|
August 25, 2004
Measurement of strange-quark contributions to the nucleon's form factors at Q(2) = 0.230 (GeV/c)(2)
F E Maas, P Achenbach, K Aulenbacher, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Advancing breast cancer research through real-world data from the Singapore Joint Breast Cancer Registry
F Y Wong, B J G Chua, R Dent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial
H C Toh, M-H Yang, H-M Wang, et al.
Page
of 62
Search research articles
Search
Showing results (591-600 of 611) with videos related to
Sort By:
Page
of 62
Physical Review Letters
|
March 24, 2005
Measurement of the transverse beam spin asymmetry in elastic electron-proton scattering and the inelastic contribution to the imaginary part of the two-photon exchange amplitude
F E Maas, K Aulenbacher, S Baunack, et al.
Journal of Crohn'S & Colitis
|
January 5, 2025
A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn's perianal fistulas
Michael De Gregorio, Leon S Winata, Imogen Hartley, et al.
Physical Review Letters
|
July 22, 2017
New Measurements of the Beam Normal Spin Asymmetries at Large Backward Angles with Hydrogen and Deuterium Targets
D Balaguer Ríos, K Aulenbacher, S Baunack, et al.
Physical Review Letters
|
June 13, 2009
Measurement of strange quark contributions to the vector form factors of the proton at Q2 = 0.22 (GeV / c)2
S Baunack, K Aulenbacher, D Balaguer Ríos, et al.
Physical Review Letters
|
April 14, 2020
Study of Two-Photon Exchange via the Beam Transverse Single Spin Asymmetry in Electron-Proton Elastic Scattering at Forward Angles over a Wide Energy Range
B Gou, J Arvieux, K Aulenbacher, et al.
Physical Review Letters
|
May 21, 2005
Evidence for strange-quark contributions to the nucleon's form factors at Q2=0.108 (GeV/c)2
F E Maas, K Aulenbacher, S Baunack, et al.
Plos One
|
January 4, 2014
Tricyclic GyrB/ParE (TriBE) inhibitors: a new class of broad-spectrum dual-targeting antibacterial agents
Leslie W Tari, Xiaoming Li, Michael Trzoss, et al.
Physical Review Letters
|
August 25, 2004
Measurement of strange-quark contributions to the nucleon's form factors at Q(2) = 0.230 (GeV/c)(2)
F E Maas, P Achenbach, K Aulenbacher, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Advancing breast cancer research through real-world data from the Singapore Joint Breast Cancer Registry
F Y Wong, B J G Chua, R Dent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 6, 2024
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial
H C Toh, M-H Yang, H-M Wang, et al.
Page
of 62